{"schema_version":1,"experiment_id":"eoa_inverse_innovation_exp03_full320_20260801","cell_id":"deadweight_loss_reduction__innovation_entrepreneurship","trajectory_id":"R","attempt_index":0,"archetype_slug":"deadweight_loss_reduction","domain_slug":"innovation_entrepreneurship","decision":"CANDIDATE","problem_id":"production_grade_controls_block_low_risk_startup_experiments","causal_lever_id":"risk_tiered_startup_sandbox_approval","proposal":{"problem":"Established organizations often apply production-grade vendor, security, integration, and procurement requirements to small, reversible startup experiments. When experiment exposure is materially lower than production exposure, this coarse approval rule can kill mutually valuable learning before a pilot begins, leaving startup solutions and organizational test capacity unused while providing protection disproportionate to the bounded risk.","actors_substrate":["startups seeking design partners or pilot customers","innovation and business-unit sponsors","procurement, security, privacy, legal, and compliance reviewers","employees or customers whose data or workflows could be exposed","incumbent vendors and rejected applicants","organizational pilot environments and budgets"],"observable_state":"Low-risk startup experiments are abandoned or delayed at production-grade approval gates; sponsors use synthetic workarounds or incumbents, pilot capacity remains unused, and few applicants progress far enough to generate decision-relevant evidence.","consequence":"Potentially useful innovations are rejected before their value can be tested, startups lose validation opportunities, and organizations make adoption decisions with less evidence.","affected_objective":"Increase safe, equitable, decision-relevant experimentation with novel products without weakening production controls or shifting risk to data subjects and users.","structural_mapping":[{"archetype_element":"value-blocking wedge","domain_realization":"A single production-grade approval path governs both bounded experiments and live operational deployments.","claim_kind":"HYPOTHESIS"},{"archetype_element":"foregone mutually beneficial activity","domain_realization":"Startups and organizational sponsors who both want a limited experiment cannot conduct it, so product-value learning is not produced.","claim_kind":"INFERENCE"},{"archetype_element":"protected purpose","domain_realization":"Security, privacy, legal compliance, accessibility, safety, procurement integrity, and accountable deployment remain mandatory.","claim_kind":"INFERENCE"},{"archetype_element":"less-distortive redesign","domain_realization":"A risk-tiered sandbox permits only low-exposure experiments under isolation, data minimization, time limits, and production re-review.","claim_kind":"HYPOTHESIS"},{"archetype_element":"incidence and behavioral response","domain_realization":"Faster entry may benefit startups and sponsors but increase reviewer workload, application volume, gaming, incumbent displacement, or exposure of affected users.","claim_kind":"HYPOTHESIS"}],"component_map":[{"component":"Distortion Map","status":"direct","domain_realization":"Trace each approval requirement to blocked experiments and distinguish production risks from sandbox risks."},{"component":"Protected Constraint Safeguard","status":"direct","domain_realization":"Retain non-waivable privacy, security, safety, rights, accessibility, and legal checks; prohibit automatic production access."},{"component":"Surplus Estimate","status":"direct","domain_realization":"Estimate additional decision-relevant experiments, time saved, unused pilot capacity activated, and learning value, with uncertainty."},{"component":"Affected-Party Incidence Map","status":"direct","domain_realization":"Record effects on startups, sponsors, reviewers, users, data subjects, incumbents, and rejected applicants."},{"component":"Redesign Lever","status":"direct","domain_realization":"Create a risk-tiered sandbox approval path for isolated, low-exposure experiments."},{"component":"Distributional Review","status":"direct","domain_realization":"Check whether eligibility, fees, sponsor access, or review discretion systematically exclude smaller or under-connected founders."},{"component":"Behavioral Response Model","status":"direct","domain_realization":"Model increased applications, risk misclassification, scope creep, sponsor bypass, reviewer congestion, and substitution from incumbents."},{"component":"Implementation Boundary","status":"direct","domain_realization":"Limit the test by participant count, duration, data class, system access, spend, and operational criticality."},{"component":"Monitoring and Rebound Check","status":"direct","domain_realization":"Track cycle time, completions, incidents, complaints, reviewer load, scope changes, and production conversion quality."},{"component":"Rollback or Adjustment Rule","status":"direct","domain_realization":"Suspend admissions, revoke sandbox credentials, restore the standard path, or tighten tier criteria when triggers fire."},{"component":"Cost–Benefit Assessment Frame","status":"direct","domain_realization":"Compare recovered learning and capacity with setup, review, incident, transition, and opportunity costs."},{"component":"Price-Wedge Diagnostic","status":"omitted","domain_realization":"Verify that fees are not binding; the proposed wedge is approval scope rather than price."},{"component":"Friction Source Breakdown","status":"direct","domain_realization":"Separate substantive controls from redundant documents, serial handoffs, production-only evidence, and open-ended queues."},{"component":"Compensating Adjustment Plan","status":"adapted","domain_realization":"Replace waived production controls with sandbox isolation, synthetic or minimized data, logging, insurance where appropriate, and human supervision."},{"component":"Legitimacy and Authority Review","status":"direct","domain_realization":"Confirm which body can classify risk, grant experimental access, and stop a pilot without overriding statutory duties."},{"component":"Sensitivity Analysis","status":"direct","domain_realization":"Vary expected experiment value, incident probability, reviewer cost, application growth, and conversion assumptions."},{"component":"Pilot or Sunset Path","status":"direct","domain_realization":"Run the pathway temporarily for a small cohort; it expires unless evidence supports renewal."}],"mechanism_dispositions":[{"slug":"congestion_or_capacity_pricing_adjustment","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"The queue is governed by approval scope, not peak-time pricing; charging applicants could worsen access.","counterfactual_removal":"No material change to the proposed causal chain."},{"slug":"cost_benefit_assessment_protocol","disposition":"selected_supporting","contribution_type":"TEST_DESIGN","adaptation_or_rejection":"Compare learning recovered against review, safeguard, incident, and distributional costs under sensitivity ranges.","counterfactual_removal":"The pilot could still operate, but continuation would lack a disciplined welfare and incidence test."},{"slug":"distortion_reduction_review","disposition":"selected_load_bearing","contribution_type":"CORE_CAUSAL","adaptation_or_rejection":"Determine whether production-grade requirements exceed the risks of bounded experiments and identify protected checks.","counterfactual_removal":"There would be no defensible basis for treating the approval rule as an avoidable wedge."},{"slug":"impact_assessment_table","disposition":"selected_supporting","contribution_type":"SAFETY_GUARDRAIL","adaptation_or_rejection":"Register party-level gains, losses, protected interests, uncertainties, and stop signals.","counterfactual_removal":"Aggregate throughput could conceal harms or unequal access, weakening the safety gate."},{"slug":"matching_improvement_program","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"The target cases already have a willing startup and sponsor; discovery and pairing are not the binding constraint.","counterfactual_removal":"No material change where willing counterparties are already matched."},{"slug":"permit_or_approval_streamlining","disposition":"selected_load_bearing","contribution_type":"CORE_CAUSAL","adaptation_or_rejection":"Risk-tier the pathway, parallelize review, reuse evidence, and ring-fence substantive checks.","counterfactual_removal":"The coarse approval gate remains, so bounded experiments continue to die before producing evidence."},{"slug":"price_control_redesign","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"No administered product price, ceiling, floor, or subsidy is implicated.","counterfactual_removal":"No effect."},{"slug":"quota_or_allocation_rule_review","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"Use only if evidence shows a stale pilot-slot allocation, which is not the hypothesized primary wedge.","counterfactual_removal":"The approval-scope intervention remains intact."},{"slug":"regulatory_simplification_pilot","disposition":"selected_load_bearing","contribution_type":"SAFETY_GUARDRAIL","adaptation_or_rejection":"Test the lighter path in an isolated cohort with monitoring and automatic expiry.","counterfactual_removal":"The change would lose its bounded, reversible evidence path and would not be viable under uncertainty."},{"slug":"sunset_clause_review","disposition":"selected_supporting","contribution_type":"OPERATIONAL","adaptation_or_rejection":"Sunset the experimental pathway and require evidence-based renewal; do not sunset underlying legal protections.","counterfactual_removal":"The causal lever remains, but an ineffective or unsafe exception could persist by inertia."},{"slug":"tariff_fee_or_toll_redesign","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"The hypothesized barrier is not an authority-imposed charge.","counterfactual_removal":"No effect."}],"causal_chain":["Production-grade requirements are applied to materially lower-risk experiments.","Expected delay, proof burden, and uncertainty make sponsors or startups abandon experiments before launch.","A bounded risk tier replaces production-only controls with safeguards proportionate to sandbox exposure.","More eligible experiments launch and generate evidence while production deployment still requires full review.","Measured learning, incidents, access distribution, and reviewer load determine renewal, adjustment, or rollback."],"baseline":"Every startup pilot follows the ordinary production vendor and deployment pathway, with case-by-case exceptions dependent on sponsor escalation.","nearest_rival":"A startup–sponsor matching or accelerator program; it is closer only if willing counterparties cannot find one another rather than being blocked after matching.","authority_safety":{"affected_parties":["startup applicants","organizational sponsors and reviewers","employees and customers exposed to experiments","data subjects","incumbent vendors","applicants lacking internal sponsors"],"decision_authority":"The organization’s formally delegated procurement, security, privacy, legal, and business owners jointly authorize only the experimental tier; statutory regulators and affected-party rights remain controlling.","authorized_first_step":"For one business unit, admit at most ten pre-matched experiments for no more than ninety days, using synthetic or minimized data, isolated credentials, no autonomous consequential decisions, logged access, named owners, and full production re-review.","excluded_actions":["waiving statutory or contractual duties","using sensitive personal data without an authorized basis","deploying into safety-critical or production workflows","treating sandbox approval as production approval","expanding scope without reclassification","making irreversible decisions affecting nonconsenting parties"],"halt_rollback":"Immediately isolate an experiment after a material incident, unauthorized access, boundary breach, serious complaint, or risk misclassification; pause new admissions if incident or reviewer-load thresholds are crossed, revert cases to the ordinary pathway, and let the pilot expire absent affirmative renewal."}},"negative_tests":{"strongest_counterevidence":"Rejected experiments may disproportionately lack product value, sponsor commitment, security maturity, or integration readiness; the full review may be screening genuine risk rather than destroying surplus.","analogy_break":"Unlike a separable permit process, digital experiments can create production-like privacy, cybersecurity, reputational, or decision harms even at small scale; if exposure cannot be isolated, a lighter tier does not preserve the protected purpose.","failure_condition":"The sandbox increases starts but produces boundary breaches, material harms, inequitable access, reviewer overload, or low-quality evidence without a credible offsetting gain.","problem_falsifier":"Among pre-matched proposed experiments, production-grade requirements do not materially predict abandonment or delay after controlling for product readiness, sponsor commitment, integration needs, and genuine risk, or nearly all requirements remain necessary at sandbox scale.","intervention_falsifier":"Eligible sandbox cases do not improve time-to-launch or completion relative to comparable ordinary-path cases, or any improvement fails the predeclared safety, rights, equity, reviewer-load, and evidence-quality thresholds.","risks":["risk understatement to enter the lighter tier","scope creep after approval","privacy, cybersecurity, safety, or accessibility harm","innovation theater that raises starts without useful learning","review congestion from induced demand","preferential access for well-connected founders","unfair displacement of incumbents","sandbox approval being misrepresented as production validation"]},"null_rationale":null,"classification":{"candidate_kind":"MECHANISM_COMPOSITION","prior_art_status":"UNSEARCHED","evidence_maturity":"HYPOTHESIS"},"revision_change_log":{"revision_kind":"ORIGINAL","prior_problem_id":null,"prior_causal_lever_id":null,"problem_changed":false,"causal_lever_changed":false,"conceptual_changes":[],"operational_changes":[],"repairs_addressed":[]},"confidence":0.88,"generator_notes":"Closed-book structural inference from the supplied packet; empirical prevalence, effect size, and prior art remain unverified."}